Record Q2 revenue of $5.46B propels TI's Q3 guidance above consensus
TXN sits 92% above its 52-week low of $152.73.
Summary
Texas Instruments posted Q2 2026 revenue of $5.46 billion, a 23% YoY increase, and EPS of $2.14, beating estimates. Q3 guidance of $5.65–$6.15 billion in revenue and $2.23–$2.57 EPS came in above consensus, signaling sustained demand in key end markets.
Key Events · Earnings and Guidance · TXN
-
Q2 Revenue and EPS Beat
Revenue of $5.46 billion grew 23% year-over-year, driven by industrial, data center, and automotive demand. EPS of $2.14 included a $0.05 benefit not in original guidance.
-
Q3 Guidance Above Consensus
TI guided Q3 revenue to $5.65–$6.15 billion and EPS to $2.23–$2.57, both above analyst expectations, indicating continued growth momentum.
-
Free Cash Flow Surge
Trailing 12-month free cash flow reached $6.5 billion, or 33.6% of revenue, boosted by $1.18 billion in CHIPS Act incentives and strong operating cash flow of $8.67 billion.
-
Shareholder Returns
TI returned $5.8 billion to shareholders over the past 12 months via $5.1 billion in dividends and $707 million in buybacks, though repurchases slowed significantly from prior year.
Analysis · TXN · Manufacturing
A standout second quarter saw revenue climb 23% year-over-year to $5.46 billion, while EPS reached $2.14, comfortably exceeding expectations. Looking ahead, third-quarter revenue is guided to $5.65–$6.15 billion and EPS to $2.23–$2.57, both ahead of analyst estimates. Trailing twelve-month free cash flow surged to $6.5 billion, fueled by CHIPS Act incentives and operational leverage. The performance underscores TI's dominance in analog and embedded processing, with broad-based strength across industrial, data center, and automotive markets. Although the wide guidance range reflects lingering macroeconomic uncertainty, the outlook signals sustained momentum into the second half.
At the time of this filing, TXN was trading at $293.17 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $267.7B. The 52-week trading range was $152.73 to $334.03. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.